JP2024501453A5 - - Google Patents

Info

Publication number
JP2024501453A5
JP2024501453A5 JP2023535317A JP2023535317A JP2024501453A5 JP 2024501453 A5 JP2024501453 A5 JP 2024501453A5 JP 2023535317 A JP2023535317 A JP 2023535317A JP 2023535317 A JP2023535317 A JP 2023535317A JP 2024501453 A5 JP2024501453 A5 JP 2024501453A5
Authority
JP
Japan
Application number
JP2023535317A
Other languages
Japanese (ja)
Other versions
JP2024501453A (ja
JPWO2022125891A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/062797 external-priority patent/WO2022125891A2/en
Publication of JP2024501453A publication Critical patent/JP2024501453A/ja
Publication of JP2024501453A5 publication Critical patent/JP2024501453A5/ja
Publication of JPWO2022125891A5 publication Critical patent/JPWO2022125891A5/ja
Withdrawn legal-status Critical Current

Links

JP2023535317A 2020-12-11 2021-12-10 抗ceaイムノコンジュゲート、及びそれらの使用 Withdrawn JP2024501453A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063124353P 2020-12-11 2020-12-11
US63/124,353 2020-12-11
PCT/US2021/062797 WO2022125891A2 (en) 2020-12-11 2021-12-10 Anti-cea immunoconjugates, and uses thereof

Publications (3)

Publication Number Publication Date
JP2024501453A JP2024501453A (ja) 2024-01-12
JP2024501453A5 true JP2024501453A5 (https=) 2024-12-10
JPWO2022125891A5 JPWO2022125891A5 (https=) 2024-12-10

Family

ID=79425667

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023535317A Withdrawn JP2024501453A (ja) 2020-12-11 2021-12-10 抗ceaイムノコンジュゲート、及びそれらの使用

Country Status (6)

Country Link
US (1) US20240238430A1 (https=)
EP (1) EP4259210A2 (https=)
JP (1) JP2024501453A (https=)
CN (1) CN116635084A (https=)
CA (1) CA3200051A1 (https=)
WO (1) WO2022125891A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023154318A1 (en) * 2022-02-09 2023-08-17 Bolt Biotherapeutics, Inc. Anti-tr0p2, aminobenzazepine immunoconjugates, and uses thereof
WO2024173387A1 (en) 2023-02-14 2024-08-22 Bolt Biotherapeutics, Inc. Aza-benzazepine immunoconjugates, and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007089A1 (en) 1987-03-18 1988-09-22 Medical Research Council Altered antibodies
US5874540A (en) 1994-10-05 1999-02-23 Immunomedics, Inc. CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
CA2399940A1 (en) 2000-04-13 2001-10-25 The Rockefeller University Enhancement of antibody-mediated immune responses
US7232888B2 (en) 2002-07-01 2007-06-19 Massachusetts Institute Of Technology Antibodies against tumor surface antigens
WO2005086875A2 (en) 2004-03-11 2005-09-22 City Of Hope A humanized anti-cea t84.66 antibody and uses thereof
KR101270829B1 (ko) 2004-09-23 2013-06-07 제넨테크, 인크. 시스테인 유전자조작 항체 및 접합체
WO2006073921A2 (en) 2004-12-30 2006-07-13 The Rockefeller University Compositions and methods for enhanced dendritic cell maturation and function
US20080286819A1 (en) 2005-11-07 2008-11-20 Ravetch Jeffrey V Reagents, Methods and Systems for Selecting a Cytotoxic Antibody or Variant Thereof
LT1976880T (lt) 2005-12-21 2016-10-10 Amgen Research (Munich) Gmbh Farmacinės kompozicijos, pasižyminčios atsparumu tirpiam cea
EP2144628B1 (en) 2007-05-08 2012-10-17 Genentech, Inc. Cysteine engineered anti-muc16 antibodies and antibody drug conjugates
MX2010003718A (es) 2007-10-19 2010-04-21 Genentech Inc Anticuerpos anti-tenb2 producidos por ingenieria de cisteina y conjugados de farmaco y anticuerpo.
JP5889912B2 (ja) 2010-11-17 2016-03-22 ジェネンテック, インコーポレイテッド アラニニルメイタンシノール抗体コンジュゲート
RS56793B1 (sr) 2011-03-02 2018-04-30 Roche Glycart Ag Cea antitela
HUE033369T2 (en) 2012-11-20 2017-11-28 Sanofi Sa Anti-ceacam5 antibodies and uses thereof
US9676863B2 (en) 2014-02-10 2017-06-13 Merck Patent Gmbh Targeted TGFβ inhibitors
MY189836A (en) 2014-11-21 2022-03-11 Bristol Myers Squibb Co Antibodies against cd73 and uses thereof
AU2019337654A1 (en) * 2018-09-12 2021-04-08 Silverback Therapeutics, Inc. Substituted benzazepine compounds, conjugates, and uses thereof
WO2020252254A1 (en) * 2019-06-13 2020-12-17 Bolt Biotherapeutics, Inc. Macromolecule-supported aminobenzazepine compounds
AU2020291014B2 (en) * 2019-06-13 2025-06-05 Bolt Biotherapeutics, Inc. Aminobenzazepine compounds, immunoconjugates, and uses thereof
CN115996756A (zh) * 2020-05-08 2023-04-21 博尔特生物治疗药物有限公司 弹性蛋白酶底物肽连接子免疫缀合物及其用途

Similar Documents

Publication Publication Date Title
JP2022537158A5 (https=)
JP2023524271A5 (https=)
JP2024501453A5 (https=)
BR102021007058A2 (https=)
CN305533106S (https=)
CN305533920S (https=)
CN306317884S (https=)
CN306316178S (https=)
CN306314083S (https=)
CN306211854S (https=)
CN306210643S (https=)
CN306209466S (https=)
CN305536169S (https=)
CN305536071S (https=)
CN305535256S (https=)
CN305535081S (https=)
CN305534904S (https=)
CN305534266S (https=)
CN306206363S (https=)
CN305532605S (https=)
CN306200497S (https=)
CN306195395S (https=)
CN306318329S (https=)
CN306331331S (https=)
CN306191295S (https=)